Zeta Surgical has received FDA 510(k) clearance for its TMS Robotic System as a stereotactic instrument, expanding its portfolio of robotic technologies for transcranial magnetic stimulation (TMS).
The system is designed to provide real-time robotic...
Zeta Surgical has received FDA 510(k) clearance for its TMS Robotic System as a stereotactic instrument, expanding its portfolio of robotic technologies for transcranial...
Spiro Robotics has received FDA 510(k) clearance for Spiro-VISTA, its handheld, dual image-guided robotic system designed to assist with tracheal intubation in adult hospital...
From scaling new cancer treatment approaches to expanding personalized medicine and developing smarter diagnostic tools, this week’s MedTech financings show continued investor confidence in...
Stereotaxis has completed its previously announced acquisition of Robocath in a deal valued at up to $45 million, strengthening its position in the endovascular...
Nyra Medical has enrolled the first patient in its ENHANCE early feasibility study evaluating the investigational CARLEN transcatheter cardiac leaflet enhancer for patients with...
AtaCor Medical has enrolled the first patient in the ALARION-EV pivotal trial evaluating its next-generation extravascular implantable cardioverter-defibrillator (EV-ICD) system, developed in partnership with...
Reflow Medical has enrolled the first patient in the DEEPER CHALLENGE study evaluating its Spur Peripheral Retrievable Scaffold System for below-the-knee treatment in patients...
Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology, showcasing highly positive results for...
Zeta Surgical has received FDA 510(k) clearance for its TMS Robotic System as a stereotactic instrument, expanding its portfolio of robotic technologies for transcranial...
Spiro Robotics has received FDA 510(k) clearance for Spiro-VISTA, its handheld, dual image-guided robotic system designed to assist with tracheal intubation in adult hospital...
From scaling new cancer treatment approaches to expanding personalized medicine and developing smarter diagnostic tools, this week’s MedTech financings show continued investor confidence in...
Stereotaxis has completed its previously announced acquisition of Robocath in a deal valued at up to $45 million, strengthening its position in the endovascular...